Interesting overview by Sapphire Ventures of AI companies that are attacking the drug development stack potentially replacing services spend. Some interesting companies called out hear and not all Sapphire portfolio companies.
Interesting overview by Sapphire Ventures of AI companies that are attacking the drug development stack potentially replacing services spend. Some interesting companies called out hear and not all Sapphire portfolio companies.